Abstract

Shape-selective recognition of nucleic acid structures by supramolecular drugs offers the potential to treat disease. The Trans Activation Response (TAR) region is a region of high secondary structure within the human immunodeficiency virus-1 (HIV-1) RNA that complexes with the virus-encoded Transactivator protein (TAT) and regulates viral transcription. Herein, we explore different metallo-supramolecular triple stranded helicates (cylinders) that target the TAR bulge motif and inhibit the formation of TAR-TAT complexes and HIV infection. Cylinders that incorporate Ni(II) and Ru(II) showed the most potent anti-viral activity with limited evidence of cellular cytotoxicity. These metallo-supramolecular compounds provide an exciting avenue for developing a new class of anti-viral agents.

Highlights

  • Ribonucleic acid (RNA) is involved in a wide range of biological events, mediating the processing of genetic information from DNA to proteins, as structural components of many ribonucleoproteins and as non-coding elements with a variety of gene regulatory functions[1,2]

  • The retrovirus human immunodeficiency virus type 1 (HIV-1) encodes a Trans Activation Response (TAR) RNA element that comprises a conserved 59-nucleotide stem-loop structure located within the 5′ end of the transcribed viral mRNA (Fig. 1a) in the long terminal repeat (LTR)

  • The highly conserved HIV TAR motif provides an attractive target for the design of small molecules that inhibit TAR-transactivator protein (TAT) complex formation; to date there has been a paucity of agents targeting this step in the viral life cycle

Read more

Summary

Introduction

Ribonucleic acid (RNA) is involved in a wide range of biological events, mediating the processing of genetic information from DNA to proteins, as structural components of many ribonucleoproteins and as non-coding elements with a variety of gene regulatory functions[1,2]. We address these challenges and demonstrate that alternative metal containing supramolecular cylinders bind TAR RNA and reduce ADP-1 interaction(s) and importantly inhibit HIV replication in cell based systems with no significant toxicity.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call